Alejandro Jiménez‐Navas

机构：Centro de Investigación del Cáncer

发表论文 10 篇 · 总被引 44 次 · h-index 3

代表论文

• Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer (2022 · Cancers · 被引 24)
• A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice (2024 · EBioMedicine · 被引 10)
• NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence (2024 · Clinical and Translational Medicine · 被引 7)
• AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study (2024 · medRxiv · 被引 2)
• Evolutionary Origins of Metabolic Reprogramming in Cancer (2022 · International Journal of Molecular Sciences · 被引 1)
• AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors (2026 · Cancer Letters)